PFMT+BF studies | Treatment time | N (subjects) | N (% lost to follow-up) | % cure | % cure/improved | N (%) positive & statistically significant outcomes |
---|---|---|---|---|---|---|
Morkved (2002) | 6 months | 53 | 5 (9) | 58 (1); 65 (2) 40 (3) | 97 (3) | 6 (100) |
Berghmans (1996) | 4 weeks | 20 | 0 (0) | 25 (2) | 95 (2) | 1 (100) |
Knight (1998) | 6 months | 21 | 3 (14) | NR | 72 (1) 56 (3) | 2 (100) |
Wong (2001) a | 4 weeks | 19 | 0 (0) | NR | NR | 3/5 (60) |
Wong (2001)b | 4 weeks | 19 | 0 (0) | NR | NR | 4/5 (80) |
Johnson (2001) a | 6 weeks | 16 | 0 (0) | 25 (3) | NR | 4 (100) |
Johnson (2001) b | 6 weeks | 16 | 0 (0) | 38 (3) | NR | 2/4 (80) |
Cammu & van Nylen (1998) | 12 weeks | 30 | 0 (0) | 53 (3) | NR | NR |
Pieber (1995) | 3 months | 25 | 11 (44) | 22 (3) | 86(4) | NR |
Glavind (1996) | 4 weeks | 20 | 1 (5) | 58 (4) | NR | NR |
Pages (2001) | 1 month | 24 | 11 (46) | 62 (3) | 100 (3) | 1 (100) |
Aksac (2003) | 8 weeks | 20 | NR | 80 (4) | 100 (4) | 8 (100) |
Balmforth (2004) | 14 weeks | 97 | NR | NR | NR | 5 (100) |